HRMY

HRMY Operating Cash Flow (Statement)

$355.08MTTM · USD

Period ending:

HRMY FY Cash from OperationsUSD
HRMY FY Cash from Operations2018-12-31: -$38.80M2019-12-31: -$75.44M2020-12-31: -$2.99M2021-12-31: $98.56M2022-12-31: $144.47M2023-12-31: $219.39M2024-12-31: $219.82M2025-12-31: $348.20M$348.20M-$75.44M
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HRMY operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Harmony Biosciences Hldg Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
348,199,000
219,821,000
219,387,000
144,466,000
98,557,000
-2,985,000
-75,436,000
-38,799,000

Compare operating cash flow (statement)

All HRMY financial metrics · HRMY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.